$6.70
-0.11-1.62%
Pre-Market: 4:19 PM EDT
Comments
Loading...
Bausch Health Companies Stock Guidance | NYSE:BHC | Benzinga
Bausch Health Companies issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/19/2025 | BHC | Bausch Health Companies | FY | 2025 | — | — | — | $9.90B | $10.15B | $9.91B | Get Alert |
| 10/30/2024 | BHC | Bausch Health Companies | FY | 2024 | — | — | — | $9.50B | $9.68B | $9.49B | Get Alert |
| 08/01/2024 | BHC | Bausch Health Companies | FY | 2024 | — | — | — | $9.40B | $9.65B | $9.40B | Get Alert |
| 05/02/2024 | BHC | Bausch Health Companies | FY | 2024 | — | — | — | $9.30B | $9.55B | $9.39B | Get Alert |
| 02/22/2024 | BHC | Bausch Health Companies | FY | 2024 | — | — | — | $9.30B | $9.55B | $9.02B | Get Alert |
| 11/02/2023 | BHC | Bausch Health Companies | FY | 2023 | — | — | — | $8.59B | $8.71B | $8.49B | Get Alert |
| 08/03/2023 | BHC | Bausch Health Companies | FY | 2023 | — | — | — | $8.45B | $8.65B | $8.35B | Get Alert |
| 05/04/2023 | BHC | Bausch Health Companies | FY | 2023 | — | — | — | $8.35B | $8.55B | $8.35B | Get Alert |
| 02/23/2023 | BHC | Bausch Health Companies | FY | 2023 | — | — | — | $4.45B | $4.60B | $8.31B | Get Alert |
| 11/03/2022 | BHC | Bausch Health Companies | FY | 2022 | — | — | — | $8.00B | $8.17B | $11.05B | Get Alert |
| 08/09/2022 | BHC | Bausch Health Companies | FY | 2022 | — | — | — | $8.05B | $8.22B | $8.34B | Get Alert |
| 05/10/2022 | BHC | Bausch Health Companies | FY | 2022 | — | — | — | $8.25B | $8.40B | — | Get Alert |
| 02/23/2022 | BHC | Bausch Health Companies | FY | 2022 | — | — | — | $8.40B | $8.60B | — | Get Alert |
| 11/02/2021 | BHC | Bausch Health Companies | FY | 2021 | — | — | — | $8.40B | $8.60B | — | Get Alert |
| 08/03/2021 | BHC | Bausch Health Companies | FY | 2021 | — | — | — | $8.40B | $8.60B | $8.64B | Get Alert |
| 05/04/2021 | BHC | Bausch Health Companies | FY | 2021 | — | — | — | $8.60B | $8.80B | $8.66B | Get Alert |
| 02/24/2021 | BHC | Bausch Health Cos | FY | 2021 | — | — | — | $8.60B | $8.80B | $8.50B | Get Alert |
| 01/12/2021 | BHC | Bausch Health Cos | FY | 2020 | — | — | — | $8.00B | — | $7.93B | Get Alert |
| 01/12/2021 | BHC | Bausch Health Cos | Q4 | 2020 | — | — | — | $2.20B | — | $2.12B | Get Alert |
| 11/03/2020 | BHC | Bausch Health Companies | FY | 2020 | — | — | — | $7.80B | $8.00B | $7.89B | Get Alert |
| 10/08/2020 | BHC | Bausch Health Companies | Q3 | 2020 | — | — | — | $2.10B | — | $1.98B | Get Alert |
| 10/08/2020 | BHC | Bausch Health Companies | FY | 2020 | — | — | — | $7.80B | $8.00B | $7.86B | Get Alert |
| 08/06/2020 | BHC | Bausch Health Companies | FY | 2020 | — | — | — | $7.80B | $8.00B | $8.05B | Get Alert |
FAQ
What is the most recent guidance for Bausch Health Companies (BHC)?
There have been no specific sales or earnings guidance reported for Bausch Health Companies in recent months.
Browse guidance and forecast on all stocks.